Considerations and challenges for the achievement of targeted gene delivery

Gene Therapy

Volumn 6, Issue 9, 1999, Pages 1497-1498

  Curiel, D T ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; COXSACKIE VIRUS; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; PRIORITY JOURNAL; RETROVIRUS; SHORT SURVEY; TOXICITY; VIRUS REPLICATION;

ADENOVIRIDAE; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS;

ADENOVIRIDAE; COXSACKIEVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0032830473     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301038     Document Type: Short Survey

References (12)

1. Grubb BR et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 1994; 371: 802-806.
2. Crystal RG et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis [see comments]. Nat Genet 1994; 8: 42-51.
3. Pickles RJ et al. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol 1998; 72: 6014-6023.
4. Vanderkwaak TJ et al. An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches. Gynecologic Oncology (in press).
5. Dmitriev I et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 1998; 72: 9706-9713.
6. Kasono K et al. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Clin Cancer Res (in press).
7. McDonald D et al. Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells. Gene Therapy 1999; 6: 1512-1519.
8. Bergelson JM et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275:1320-1323.
9. Hong SS et al. Adenovirus type 5 fiber knob binds to MHC class stoid cells. EMBO J 1997; 16: 2294-2306.
10. v-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Therapy 1999; 6: 1520-1535.
11. Smith AE. Viral vectors for gene therapy. Ann Rev Microbiol 1995; 49: 807-838.
12. Reynolds PN, Curiel DT. Strategies to adapt adenoviral vectors for gene therapy applications: targeting and integration. In: Friedmann T (ed). The Development of Human Gene Therapy. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, 1998, pp 111-130.